https://doi.org/10.1016/s2215-0366(22)00375-3
R
Rafael Gafoor
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
894
Citations
12
h-index
15
i10-index
Rafael Gafoor is an academic researcher from MRC Clinical Trials Unit at UCL. The author has contributed to research in topics: Schizophrenia research and treatment & Cannabis and Cannabinoid Research & Healthcare professionals’ stress and burnout. The author has an h-index of 12, co-authored 44 publications.
ORCID: 0000-0001-6865-1270Papers by this author
worksPrevalence of post-traumatic stress disorder and common mental disorders in health-care workers in England during the COVID-19 pandemic: a two-phase cross-sectional study
2022 · The Lancet Psychiatry · 83 citations
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
2019 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-019-42087-z
Importance of Frailty for Association of Antipsychotic Drug Use With Risk of Fracture: Cohort Study Using Electronic Health Records
2019 · Journal of the American Medical Directors Association · 11 citations
https://doi.org/10.1016/j.jamda.2019.05.009
A crisis planning and monitoring intervention to reduce compulsory hospital readmissions (FINCH study): protocol for a randomised controlled feasibility study
2024 · Pilot and Feasibility Studies · 7 citations
https://doi.org/10.1186/s40814-024-01453-z
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial
2024 · Research and Practice in Thrombosis and Haemostasis · 4 citations
https://doi.org/10.1016/j.rpth.2024.102468
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat